๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

International Register of Specialists and Current Research in Plant Systematicsby R. W. Kiger; T. D. Jacobsen; R. M. Lilly

โœ Scribed by Review by: R. S. Cowan

Book ID
124308498
Publisher
International Association for Plant Taxonomy
Year
1982
Tongue
English
Weight
105 KB
Volume
31
Category
Article
ISSN
0040-0262

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

79 Preclinical pharmacokinetic evaluatio
79 Preclinical pharmacokinetic evaluation of selected members of a new class of potent HIV-1 reverse transcriptase inhibitors: C. Sahlberg1, B.-L. Sahlberg2, K. Frykman2, M. Clemens3, J. S. Kasher3, J. M. Morin, Jr.3, R. J. Ternansky3, F. W. Bell3, C. L. Jordan3, M. D. Kinnick3, J. A. Palkowitz3, C. A. Parrish3, P. Pranc3, R. T. Vasileff3, and S. J. West3. 1Medivir AB, Huddinge, Sweden; Apoteksbolaget Central Laboratory, Stockholm, Sweden; 3Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 81 KB
60 Inhibition of wild type and mutant HI
60 Inhibition of wild type and mutant HIV reverse transcriptases by a new class of non-nucleoside reverse transcriptase inhibitors: H. Zhang1, L. Vrang1, K. Backro2, T. Unge2, P. Engelhardt1, M. Hogberg2, J. Kangasmetsa1, P. Lind1, R. Noreen1, C. Sahlberg1, X.-X. Zhou1, N. G. Johansson1, A. S. Cantrell3, S. R. Jaskunas3, J. M. Morin, Jr.3, R. J. Ternansky3, F. W. Bell3, C. L. Jordan3, M. D. Kinnick3, J. A. Palkowitz3, C. A. Parrish3, P. Pranc3, R. T. Vasileff3, S. J. West3, and B. Oberg1. 1Medivir AB, Huddinge, Sweden; 2Department of Molecular Biology, BMC, Uppsala, Sweden; 3Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 57 KB
43 The discovery and general SAR studies
43 The discovery and general SAR studies of a novel class of potent non-nucleoside reverse transcriptase inhibitors: R. J. Ternansky1, J. M. Morin, Jr.1, C. Lopez1, C. J. Paget, Jr.1, F. W. Bell1, A. S. Cantrell1, S. R. Jaskunas1, C. L. Jordan1, M. D. Kinnick1, J. A. Palkowitz1, C. A. Parrish1, P. Pranc1, R. T. Vasileff1, S. J. West1, M. Hogberg2, P. Lind2, R. Noreen2, C. Sahlberg2, X.-X. Zhou2, L. Vrang2, C. Rydergard2, C. Ahgren2, B. Oberg2, and N. G. Johansson2. 1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA; 2Medivir AB, Huddinge, Sweden
๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 50 KB
71 SAR studies optimizing HIV-1 inhibiti
71 SAR studies optimizing HIV-1 inhibiting activities of LY73497, a new series of non-nucleoside inhibitors of reverse transcriptase: P. Engelhardt1, M. Hoberg1, J. Kangametsa1, P. Lind1, R. Noreen1, C. Sahlberg1, X.-X. Zhou1, L. Vrang1, H. Zhang1, B. Oberg1, N. G. Johansson1, F. W. Bell2, A. S. Cantrell2, J. A. Palkowitz2, S. R. Jaskunas2, C. L. Jordan2, M. D. Kinnick2, J. M. Morin, Jr.2, C. A. Parrish2, P. Pranc2, R. J. Ternansky2, R. T. Vasileff2, and S. J. West2. 1Medivir AB, Huddinge, Sweden; 2Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA
๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 62 KB